Effects of Clinical Pilates on Physical and Psychosocial Outcomes in Individuals With Interstitial Lung Disease

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorRecep Tayyip Erdogan University

About this trial

This study aims to investigate the effects of Clinical Pilates on physical and psychosocial outcomes in individuals with interstitial lung disease (ILD). Interstitial lung disease is a group of chronic conditions that affect lung tissue and can lead to breathing difficulties, reduced physical capacity, fatigue, and decreased quality of life.

In addition to medical treatment, exercise-based rehabilitation approaches may help individuals with ILD improve their physical function and overall well-being. Clinical Pilates is a structured exercise method that focuses on breathing control, posture, core stability, flexibility, and body awareness.

Participants in this study will be randomly assigned to either a Clinical Pilates group or a control group receiving standard care. The Clinical Pilates program will be delivered by a trained physiotherapist over several weeks through supervised sessions.

The main outcomes of this study include physical function, respiratory symptoms, quality of life, and psychological well-being. The results of this study are expected to provide evidence on whether Clinical Pilates can be an effective and safe supportive approach for pulmonary rehabilitation in individuals with interstitial lung disease.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 18 to 75 years.

Clinically confirmed diagnosis of interstitial lung disease (ILD) by a physician.

Clinically stable condition (no acute exacerbation or hospitalization related to ILD within the last 4 weeks).

On stable medical treatment and routine follow-up.

Disqualifiers

Coexisting chronic respiratory disease that may confound outcomes (e.g., COPD, uncontrolled asthma, bronchiectasis).

Acute exacerbation of ILD or hospitalization within the last 4 weeks.

Unstable cardiovascular disease or other medical conditions making exercise unsafe (e.g., unstable angina, recent myocardial infarction).

Severe neurological, musculoskeletal, or balance disorders limiting safe participation in exercise.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Clinical Pilates

    Behavioral

    A supervised Clinical Pilates exercise program conducted by a physiotherapist, including breathing-focused, posture-based, and low-impact strengthening and flexibility exercises tailored to individuals with interstitial lung disease.

  • standart care

    Other intervention

    Participants will continue their usual medical treatment and routine clinical follow-up for interstitial lung disease without additional rehabilitation intervention.

Treatment groups

58 Participants
are divided into 2 treatment groups
Group A: Clinical Pilates GroupExperimental treatment 2 interventions
Group B: Standard Care Control GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Six-Minute Walk Test Distance

Physical function will be assessed using the Six-Minute Walk Test (6MWT). Total walking distance will be recorded.

Time frame
Baseline (Week 0) and Week 8
2

Modified Medical Research Council Dyspnea Scale Score

Respiratory symptom severity will be assessed using the Modified Medical Research Council (mMRC) Dyspnea Scale total score. Points (range 0-4; higher scores indicate worse dyspnea)

Time frame
Baseline (Week 0) and Week 8

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Recep Tayyip Erdogan University

Lead sponsor

İstanbul Yeni Yüzyıl Üniversitesi

Collaborator

This trial is not recruiting at the moment. You can still explore other options: